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Original ArticleNicotinamide riboside kinases display
redundancy in mediating nicotinamide
mononucleotide and nicotinamide riboside
metabolism in skeletal muscle cellsRachel S. Fletcher 1,2, Joanna Ratajczak 3,4, Craig L. Doig 1,2, Lucy A. Oakey 2, Rebecca Callingham 5,
Gabriella Da Silva Xavier 5, Antje Garten 1,6, Yasir S. Elhassan 1,2, Philip Redpath 7, Marie E. Migaud 7,
Andrew Philp 8, Charles Brenner 9, Carles Canto 3,4, Gareth G. Lavery 1,2,*ABSTRACT
Objective: Augmenting nicotinamide adenine dinucleotide (NADþ) availability may protect skeletal muscle from age-related metabolic decline.
Dietary supplementation of NADþ precursors nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) appear efﬁcacious in elevating
muscle NADþ. Here we sought to identify the pathways skeletal muscle cells utilize to synthesize NADþ from NMN and NR and provide insight into
mechanisms of muscle metabolic homeostasis.
Methods: We exploited expression proﬁling of muscle NADþ biosynthetic pathways, single and double nicotinamide riboside kinase 1/2 (NRK1/
2) loss-of-function mice, and pharmacological inhibition of muscle NADþ recycling to evaluate NMN and NR utilization.
Results: Skeletal muscle cells primarily rely on nicotinamide phosphoribosyltransferase (NAMPT), NRK1, and NRK2 for salvage biosynthesis of
NADþ. NAMPT inhibition depletes muscle NADþ availability and can be rescued by NR and NMN as the preferred precursors for elevating muscle
cell NADþ in a pathway that depends on NRK1 and NRK2. Nrk2 knockout mice develop normally and show subtle alterations to their
NADþ metabolome and expression of related genes. NRK1, NRK2, and double KO myotubes revealed redundancy in the NRK dependent
metabolism of NR to NADþ. Signiﬁcantly, these models revealed that NMN supplementation is also dependent upon NRK activity to enhance
NADþ availability.
Conclusions: These results identify skeletal muscle cells as requiring NAMPT to maintain NADþ availability and reveal that NRK1 and 2 display
overlapping function in salvage of exogenous NR and NMN to augment intracellular NADþ availability.
 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords Skeletal muscle; NADþ; Energy metabolism; Nicotinamide riboside1. INTRODUCTION
Nicotinamide adenine dinucleotide (NADþ) was ﬁrst described as a
vital cofactor in cellular redox reactions important to cellular energy
metabolism [1,2]. NADþ also serves as a consumed substrate for
enzymes such as sirtuins that post translationally modify proteins by
deacetylation, yielding nicotinamide (NAM) and 20-and 3-O-aceyl-ADP
ribose in the process [3]. Sirtuins have been characterized as regu-
latory sensors that coordinate metabolic and transcriptional adapta-
tions to cellular and tissue energy requirements [4,5].
Skeletal muscle requires a high turnover of ATP to sustain contraction,
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consuming enzymes, replenishment of NADþ through biosynthesis and
salvage pathways is vital [7,8]. NADþ can be synthesized de novo from
tryptophan and by salvage of nicotinic acid (NA), a form of vitamin B3,
via the Preiss-Handler pathway [9,10]. Along with NA, nicotinamide
(NAM) is also called vitamin B3 (collectively termed niacin) and as a
nutrient or by recycling following NADþ consumption, is metabolized
by nicotinamide phosphoribosyltransferase (NAMPT) to nicotinamide
mononucleotide (NMN), which is converted to NADþ via NMN adeny-
lyltransferases (NMNAT) [11]. A ﬁnal route to NADþ is the salvage and
phosphorylation of the recently discovered form of vitamin B3 nico-
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Original Articlekinase 1 and 2 (NRK1 and 2) pathway [2,12,13]. Despite mammalian
cells demonstrating pathway diversity for maintaining NADþ levels in
various tissues, the relative contribution of these pathways to NADþ
biosynthesis in skeletal muscle remained unclear. The metabolic
beneﬁts of augmenting muscle NADþ availability is being realized
through the application of NADþ precursor supplementation strategies.
Historically, NA and NAM supplementation has been used to treat
hypercholesterolemia and pellagra [14]. However, undesirable side
effects in humans have limited their utility. NA causes ﬂushing through
activation of the GPR109A receptor in a large proportion of patients,
leading to poor compliance [15]. Large doses of NAM are required to
increase NADþ leading to adverse effects and NAM mediated inhibition
of sirtuin activity [16,17]. The NA derivative Acipimox has shown the
potential of using NADþ precursors to improve and enhance mito-
chondrial function and ATP content of skeletal muscle in the context of
diabetes [15].
NMN and NR have emerged as NADþ precursors with the potential to
circumvent the adverse side effects associated with high dose niacin
and augment NADþ synthesis and sirtuin activity [18]. NMN, being an
intermediate of NADþ biosynthesis, has been used to successfully
ameliorate a number of pathological scenarios, including normalization
of glucose tolerance in diet induced diabetes [19], and is able to restore
mitochondrial function in agedmuscle [20,21]. Dietary supplementation
of NR in mice can negate the metabolic consequences of high fat diet
and increase oxidative performance [22], delay disease progression in
mice with mitochondrial myopathy, inducing sirtuin dependent mito-
chondrial biogenesis and the mitochondrial unfolded protein response
[23]. In addition, NR improves glycemic control and opposes develop-
ment of diabetic neuropathy in mice and allows rats to resist devel-
opment of chemotherapeutic neuropathy [24,25]. Importantly, NR has
been shown to safely elevate human NADþ metabolism [26].
NADþ precursor utilization pathways in muscle require further deﬁ-
nition. Naturally available NR is phosphorylated to NMN by the NR
kinases (NRKs encoded by Nmrk1 and 2) [12,27], highly conserved
enzymes, but little is known of their roles in skeletal muscle [12]. It is
unclear whether NMN is truly available to muscle as an intermediate of
NADþ biosynthesis or is dependent on NRKs as a consequence of
extracellular metabolism to NR prior to cellular uptake and incorpo-
ration into the cellular NADþ pool [28]. Here we investigate NRK
expression in skeletal muscle and deﬁne the inﬂuence of NRKs on NR
and NMN metabolism to NADþ in loss-of-function muscle cells derived
from Nmrk1 and 2 knockout mice (NRK1KO, NRK2KO). We show that
the NRKs have overlapping and redundant activity in muscle cells
critical to the conversion of exogenous NR and NMN to NADþ.
2. MATERIALS AND METHODS
Unless otherwise speciﬁed all materials and reagents were acquired
from SigmaeAldrich, UK.
2.1. Animal care
Mice were group housed in a standard temperature (22 C) and
humidity-controlled environment with 12:12- hour light:dark cycle.
Nesting material was provided and mice had ad libitum access to water
and standard chow. Mice were sacriﬁced using schedule one cervical
dislocation and tissues were immediately. All experiments were in
groups of up to 6 and conducted within the UK Home ofﬁce regulations.
2.2. Generation of NRK loss of function mice
NRK2KO mice were acquired from the Jackson Laboratory. The Nmrk2
KO mutant allele was generated on a C57BL/6NTac background820 MOLECULAR METABOLISM 6 (2017) 819e832  2017 The Authors. Published by Elsevthrough the Knockout Mouse Phenotyping Program (KOMP2). A ZEN-
UB1 Velocigene cassette (beta-galactosidase coding sequence from
E. coli lacZ gene; polyadenylation signal; loxP site; promoter from the
human ubiquitin C gene; neomycin phosphotransferase; poly-
adenylation signal; loxP site) was inserted through homologous
recombination into the gene in place of all coding exons inhibiting
transcription. Deletion of Nmrk2 was validated by qPCR and
immunoblotting.
NRK1KO mice generated on a C57BL/6NTac background have been
previously described [28].
2.3. Exercise and ﬁbre-typing
As a preliminary experiment, mice (n ¼ 3) were acclimatized to the
treadmill environment and exercised 3 times a week for 1 h at 0.25 M/
Sec, at a 10 incline for 6 weeks.
Muscle sections were ﬁber typed using immunoﬂuorescence following
an established protocol [29e31]. Brieﬂy, 10 mm sections were cut
using a cryostat and mounted onto slides. Primary antibodies detecting
different myosin heavy chain subunits (BA-F8 e MHC1 (1:50), BF-F3
e MHC IIb (1:100), SC-71 (1:600) e MHC IIa, 6H1 e MHC IIx
(1:50)) (Developmental Studies Hybridoma Bank, University of Iowa)
were added, followed by ﬂuorescent secondary antibodies (IgG AF
647e Blue (1:500), IgM AF 555 e Red (1:500), IgG AF 488 e Green
(1:500)). Sections were formalin ﬁxed and mounted and then analyzed
using a Zeiss Axio Observer inverted microscope (Carl Zeiss, Germany).
Fibers were manually counted across the entire section using Image J
(Fiji) software and recorded as positive for each ﬁber expressing the
relevant visible color.
2.4. RNA extraction and qPCR
RNA was extracted from tissue and cells using TRI-reagent (Invi-
trogen). RNA quality was determined by visualization on a 1.5%
agarose gel and quantiﬁed using a nanodrop. Reverse transcription
was conducted using 500 ng RNA that was incubated with 250 mM
random hexamers, 5.5 mM MgCl2, 500 mM dNTPs, 20 units RNase
inhibitor 63 units multiscribe reverse transcriptase, and 1 reaction
buffer. Reverse transcription was performed using a thermocycler set
at the following conditions: 25 C for 10 min and 37 C for 120 min
before the reaction was terminated by heating to 85 C for 5 min qPCR
was performed in a 384-well plate in single-plex format. Primers and
probes were purchased as Assay on Demand (FAM) products (Applied
Biosystems). Total reaction volumes used were 10 ml containing
Taqman Universal PCR mix (Applied Biosystems). All Ct values were
normalized to 18s rRNA (VIC) (Applied Biosystems). The real-time PCR
reaction was performed under the following protocol: 95 C for 10 min,
then 40 cycles of 95 C for 15 s, and 60 C for 1 min using an ABI7500
system. Data were collected as Ct values and used to obtain deltaCt
(dCt) values.
2.5. Western blotting
Protein lysates were extracted from tissues in RIPA buffer (50 mmol/l
Tris pH 7.4, 1% NP40, 0.25% sodium deoxycholate, 150 mmol/l NaCl,
1 mmol/l EDTA) and protease/phosphatase inhibitor cocktail (Roche,
Lewes, U.K.). Total protein concentration was quantiﬁed by Bio-Rad
assay. Total proteins (25 mg) were resolved on a 12% SDS-PAGE
gel and transferred onto a nitrocellulose membrane. Primary anti-
bodies speciﬁc for NRK1/2 were generated and afﬁnity puriﬁed by
BioGenes (GmbH) Berlin, Germany and used at a 1:2000 dilution.
Primary antibodies including NAMPT (Abcam, USA), b-Actin (Cell
Signaling, USA, #12262) and a-Tubulin (Santa Cruz, USA, SC-5286)
were all commercially available and used at a 1:1000 dilution.ier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Secondary anti-mouse and anti-rabbit antibodies conjugated with HRP
(Dako, Denmark) were added at a dilution of 1/10,000. Equal loading of
protein content was veriﬁed using beta-actin and alpha-tubulin and
bands visualized using ECL detection system (GE Healthcare, UK).
2.6. Preparation of tissue fractions
Muscle tissue was homogenized in sucrose buffer (0.25 M sucrose,
20 mM HEPES) and centrifuged at 1000 g for 10 min at 4 C. The
supernatant was transferred to a new tube and centrifuged at 12,000 g
for 10 min at 4 C. The mitochondrial fraction was pelleted and re-
suspended in sucrose buffer and the supernatant was transferred to
ultracentrifuge tubes and, following careful balancing, centrifuged at
100,000 g for 1 h at 4 C. The supernatant containing the cytosolic
fraction was transferred to a new tube and the pellet was re-suspended
in MOPs buffer (100 mM KCl, 20 mM NaCl, 1 mMMgCl2, 20 mMMOPs)
and washed 3 times by pelleting at 100,000 g. The microsomal pellet
was re-suspended in MOPs buffer and snap frozen.
2.7. Primary muscle culture
Gastrocnemius tissue was excised from hind limbs of mice and
digested in DMEM with 0.2% collagenase at 37 C for 2 h. Digested
tissue was washed in DMEM, and media was expelled vigorously onto
the muscle to allow single myoﬁbers to detach. Myoﬁbers were then
placed in pre-set matrigel (BD biosciences) coated wells in DMEM
supplemented with 30% (v/v) FCS, 10% (v/v) HS, 1% (v/v) P/S, 2 mM L-
glutamine, 1% (v/v) chick embryo extract (CEE) (Seralab, UK), and
0.1% of ﬁbroblast growth factor (FGF) (Peprotech). Following satellite
cell migration, media was replaced with proliferation media (DMEM
with 10% (v/v) HS, 1% (v/v) P/S and 0.5% (v/v) CEE). Upon 70e80%
conﬂuence, media was replaced with Differentiation media (DMEM
supplemented with 2% (v/v) HS, 0.5% (v/v) CE,E and 1% (v/v) P/S) and
cells were differentiated for 6 days.
2.8. Cell treatments
Cells were treated in serum free media with 1 mM FK866 or DMSO as a
vehicle control for 24, 48 or 72 h. Cells were supplemented with
0.5 mM NR (ChromaDex, USA), 0.5 mM NAR, 0.5 or 5 mM NAM and
0.5 mM NMN for 24 h. A concentration of 0.5 mM for cell treatments
was used to provide a maximal effect on cellular NADþ content
following preliminary dose response experiments and previously
published work in myotubes [22].
2.9. NADþ measurements
2.9.1. NADþ by cycling assay
NADþ was extracted from primary myotubes and quantiﬁed using
EnzyChrom NAD/NADH Assay kit (BioAssay Systems) according to the
manufacturer’s instructions.
2.9.2. NADþ by HPLC
Total NAD was measured by reversed-phase HPLC using the Chro-
master Purospher STAR RP-18 endcapped 3 mm Hibar RT 150-3 HPLC
column (Merck). Frozen mouse muscle tissue (10 mg) was lysed in
100 ml 1 M perchloric acid. Samples were incubated on ice samples
for 10 min, centrifuged and the supernatant was neutralized with 3 M
potassium carbonate. After repeated centrifugation, samples were
analyzed as previously described [32].
2.10. Targeted NADþ metabolomics
20 mg of pulverised tissue samples were placed in Eppendorf tubes on
dry ice. Metabolites were extracted in 0.2 ml of ice cold LCMS gradeMOLECULAR METABOLISM 6 (2017) 819e832  2017 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.commethanol and kept on ice before adding 300 ml of internal standard
(diluted 1:300 in LC-MS grade water). Samples were brieﬂy sonicated
in an acetone water bath (at 4 C), returned to ice, and then incu-
bated at 85 C for 5 min, shaking at 1050 rpm. Samples were cooled
on ice for 5 min and centrifuged. Supernatant was dried using a speed
vacuum. The dried extract was resuspended in 40 ml of either LC-MS
grade water for acid extract or 10 mM ammonium acetate for alkaline
extract and transferred to a Waters Polypropylene 0.3 ml plastic screw-
top vial and analyzed by LC-MS/MS [33] using the ACQUITY UPLC H-
class system.
2.11. Respirometry
C2C12 cells were differentiated into fully fused myotubes for 5 days.
Respiratory output and mitochondrial stress tests were performed with
C2C12 myotubes in XF-Assay media (Agilent Technologies) supple-
mented with 25 mM glucose, 0.5 mM sodium pyruvate, pH 7.4,
maintained for 1 h at 37 C in 0% CO2 prior to Seahorse extracellular
ﬂux analysis. Extracellular ﬂux analysis was performed using the
Seahorse XF analyser following manufacturer’s instructions (Agilent
Technologies).
2.12. Cell viability and apoptosis
C2C12 cells were seeded in a 96 well plate and differentiated for 5
days. Cell viability and apoptosis were assessed using the ApoLive-
Glo multiplex assay (Promega) according to the manufacturer’s
instructions.
2.13. Statistical analysis
Unpaired Students t-test or ANOVA statistical comparisons were made
using GraphPad Software Inc. Prism version 6. Data are presented as
mean SEM with statistical signiﬁcance determined as *¼ P< 0.05,
** ¼ P < 0.01, *** ¼ P < 0.001. Statistical analysis of real-time PCR
data was determined using dCt values.
3. RESULTS
3.1. NRK2 expression exhibits highly conserved skeletal muscle
speciﬁcity
NAMPT and NADsyn1 act as rate limiting enzymes in the best char-
acterized mammalian NADþ biosynthesis pathways, with NADsyn1 the
common ﬁnal step in de novo synthesis and Preiss-Handler salvage
pathways (Figure 1A) [34]. NRK 1 and 2 were more recently identiﬁed
as NADþ salvage enzymes involved in a novel NR dependent route to
NADþ [12] (Figure 1A). To better understand the roles the NRKs play in
the context of the rate limiting enzymes NAMPT and NADsyn1, we
examined their expression in a range of tissues to determine tissue
speciﬁcity.
Using real-time PCR we show that Nmrk1 is ubiquitously expressed,
with particularly high expression in kidney, while Nmrk2 exhibits high
speciﬁcity to skeletal muscle (Figure 1B,C). Nampt is ubiquitously
expressed across different tissue types as previously described
(Figure 1D) [35], and NADsyn1 shows greatest expression in liver and
kidney tissue, consistent with previous data (Figure 1E) [36]. Nmnat1,
common to all NADþ biosynthetic pathways for conversion of NMN to
NADþ, is ubiquitously expressed (Figure 1F). We went on to endorse
these ﬁndings using Western blot analysis. While low levels of NRK1 are
detectable in muscle, it was prominently detected in whole kidney and
liver lysates (Figure 1G). For NRK2 we conﬁrmed its muscle speciﬁcity.
We also conﬁrmed the ubiquitous expression of NAMPT (Figure 1G).
Using previously generated microarray data for soleus and tibialis
anterior (TA) skeletal muscle [37], we further evaluated the relativeopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 821
Figure 1: NADD biosynthesis pathways in skeletal muscle. (A) An illustration of the known NADþ biosynthesis pathways identiﬁed in mammalian cells with exogenous
precursor supplementation strategies illustrated with dashed lines. NADþ can be synthesized de novo from tryptophan (Trp) and following multiple enzymatic reactions is converted
to nicotinic acid mononucleotide (NaMN) and then nicotinic acid dinucleotide (NaAD) by nicotinamide mononucleotide adenylyltransferase (NMNAT) activity, before the ﬁnal
conversion to NADþ by NAD synthase (NADSYN). NADþ can be salvaged from precursors nicotinic acid riboside (NaR) and nicotinic acid (NA) by nicotinamide riboside kinases
(NRK1/2) and nicotinic acid phosphoribosyltransferase (NAPRT) respectively to NaMN and follow the same ﬁnal steps. Finally, nicotinamide riboside (NR) and nicotinamide (NAM)
are salvaged by NRKs and nicotinamide phosphoribosyltransferase (NAMPT) respectively to nicotinamide mononucleotide (NMN) and ﬁnally to NADþ by NMNAT activity. Real-time
PCR mRNA expression of Nmrk1 (B), Nmrk2 (C), Nampt (D), Nadsyn1 (E), and Nmnat1 (F) across metabolic tissues. (G) Protein expression of NRK1, NRK2, and NAMPT across
metabolic tissues with corresponding densitometry compared to housekeeping protein (a-Tubulin for all tissues except liver and Wat which are compared to b-actin expression).
(H) Microarray of NADþ biosynthesis genes in tibialis anterior (TA) and soleus (Sol) skeletal muscle tissue (n ¼ 3). Real-time PCR mRNA expression of rate limiting NAD
biosynthesis genes in TA (I) and soleus (J) muscle (n ¼ 4). (K) NRK2 protein expression in TA and soleus muscle tissue. (L) NRK1, NRK2, and NAMPT protein expression in
cytosolic, mitochondrial and microsomal fractions of skeletal muscle. (Q ¼ quadriceps, TA ¼ tibialis anterior, Sol ¼ soleus, Liv ¼ liver, Hrt ¼ heart, Dia ¼ diaphragm,
Kid ¼ kidney, Brn ¼ brain and Wat ¼ white adipose tissue).
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expression of NADþ biosynthesis and salvage genes. We identiﬁed
Nmrk2, Nampt, and Nmnat1 as the most abundantly expressed genes
in soleus and TA muscle (Figure 1H). We used real-time PCR to conﬁrm
these ﬁndings and show that Nmrk2 is the most predominantly
expressed NADþ biosynthesis gene in fast twitch tibialis anterior
muscle compared to slow twitch ﬁbre rich soleus muscle (Figure 1I,J).
Western blots of soleus and tibialis anterior muscle lysates corrobo-
rated with the mRNA expression analysis, suggesting some muscle
beds are enriched with NRK2 (Figure 1K). Finally, we addressed
subcellular localization of the NRKs and NAMPT. Following fraction-
ation of skeletal muscle tissue enriched into microsomes, cytosol, and
mitochondria we show that NRK2, NRK1, and NAMPT are predomi-
nantly localized to cytosol (Figure 1L).
Although the role of NAMPT-mediated NADþ biosynthesis has been
characterized in skeletal muscle [38,39], the function of NRK1 and
NRK2 in particular, given its muscle restricted expression, and their
relative contribution to NADþ biosynthesis and homeostasis remained
ill deﬁned.
To further examine the speciﬁc roles of the NRKs, we investigated
mRNA and protein expression during C2C12 and primary muscle
myotube differentiation. In C2C12 cultures, NRK1 demonstrated low
level expression with respect to NRK2, rising to maximal expression
at day 8 (Figure 2A,D). In contrast, NRK2 expression was upregulated
during differentiation, peaking at day 4 around the time of myotube
fusion (Figure 2B,D). NAMPT expression remained constant
throughout differentiation (Figure 2C,D). We expanded this analysis to
examine primary cultures of muscle cells derived from hind limbs of
WT mice as a more physiologically relevant scenario. We used
Myogenin (MyoG), Myogenic differentiation 1 (MyoD), and a-actin 1
(ACTA1) as markers of differentiation in our primary system, with all
genes displaying anticipated proﬁles of expression for normal muscle
cell differentiation (Sup. 1A). Nmrk1, Nmrk2, and Nampt showed
similar patterns of differentiation as seen in C2C12s (Figure 2AeC).
In addition, we showed that Nmnat1 is constitutively expressed
during primary myotube differentiation (Sup. 1A). These data support
the notion of a highly conserved and speciﬁc function for NRK2 in
skeletal muscle.
3.2. NADþ turnover in skeletal muscle is predominantly regulated
by NAMPT salvage of NAM, yet NR proves a more valuable precursor
for augmenting NADþ
As the NA Preiss-Handler pathway is mostly restricted to liver NADþ
biosynthesis and NA treatment is limited due to adverse effects, we
aimed to establish the NADþ precursors and the pathways that could
be used to enhance NADþ content in skeletal muscle [15,34]. Meta-
bolic enzyme activity proﬁling data suggest that the amidated routes to
NADþ, mediated by the NAMPT and NRK salvage pathways, prevail as
the main biosynthetic routes to NADþ in muscle, which is corroborated
by our tissue expression data and molecular analysis [34].
To further assess this, we supplemented primary-derived myotubes
with NADþ precursors that could be utilized by NRK or NAMPT path-
ways; NAR (non-amidated version of NR), NR, NMN, and NAM
(Figure 1A) and quantiﬁed NADþ using a cycling assay. NAR, like NR, is
metabolized by NRKs to NAMN and then to NAAD by NMNATs [40].
However, NAAD requires ﬁnal amidation to NADþ via NAD synthetase
[41]. We found that NAR was unable to augment the NADþ pool in
muscle cells, whereas both NR and NMN supplementation signiﬁcantly
increased NADþ in myotubes by almost 2-fold. However equivalent
concentrations of NAM did not signiﬁcantly enhance NADþ, with 10-
fold excess NAM required to increase NADþ (Figure 3A). NAMPT is
considered the rate limiting step for NADþ salvage and synthesis inMOLECULAR METABOLISM 6 (2017) 819e832  2017 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.comskeletal muscle [38] but has not been explored in detail in the context
of NRKs. We examined precursor salvage and NADþ levels in myo-
tubes treated with the potent NAMPT inhibitor FK866 [42]. NAMPT is
indeed essential for basal NADþ homeostasis with NADþ levels
severely depleted (by more than 70%) following 24 h of inhibition. This
depletion was completely reversed by NR and NMN supplementation,
and both precursors were still able to boost NADþ to the same extent
as without FK866 treatment conﬁrming that NR and NMN salvage is
independent of NAMPT (Figure 3B).
To gain further insight into the activity of NR, we used LC-MS-based
targeted quantitative metabolomics. Table 1 shows levels of key
NADþ metabolites in primary myotubes treated with FK866 and NR. As
expected, NAD(H) levels signiﬁcantly increase following NR supple-
mentation, and, importantly, here we identify a large increase in cellular
NR and NMN from control cells 24 h following cell treatments. Inter-
estingly, metabolites of NADþ consumption, NAM and ADP ribose
(ADPr), were not altered by NR treatment but levels were reduced
following FK866-induced NADþ depletion, suggesting NADþ availability
is only rate limiting to NADþ signaling below normal levels (Table 1). NA
and other metabolites from the Preiss-Handler and de novo NADþ
biosynthesis pathways were undetected in primary myotubes.
NADþ is vital to mitochondrial respiration so we demonstrated the
importance of NAMPT for maintaining NADþ turnover by treating
C2C12 myotubes with FK866 for 72 h. Inhibition of NAMPT signiﬁcantly
reduced basal and maximal respiration, which was fully rescued by
treatment with NR for the ﬁnal 24 h (Figure 3C). NR alone did not
enhance mitochondrial respiration above untreated levels (Figure 3C).
Concordantly, apoptosis was stimulated in C2C12 myotubes after 48e
72 h of NAMPT inhibition. NR supplementation completely prevented
this effect (Sup. 1B).
Changes in NADþ availability and muscle cell energetics as a result of
NAMPT inhibition are known to stimulate elevated rates of NAMPT
gene transcription through AMPK activity; however, the effects on
NRKs in this context are unknown [43,44]. Using real-time PCR, we
show that cellular mRNA expression of NADþ salvage genes is tightly
regulated by NADþ availability. NADþ depletion by FK866 resulted in
upregulation of Nmrk2 and Nampt and downregulation of Nmrk1
(Figure 3D). Repletion of NADþ by NR supplementation returned mRNA
levels of all genes back to that of untreated control and NR treated cells
(Figure 3D).
These data demonstrate that NAMPT is crucial for basal NADþ
biosynthesis. NR supplementation can completely rescue NAMPT in-
hibition through NRK-mediated NADþ salvage. These data suggest that
NRK activity is independently capable of maintaining cellular NADþ and
that NR availability may restrict NRK activity under basal conditions.
3.3. Loss of NRK2 function does not impair skeletal muscle mass
or ﬁber type distribution in young mice
To further elucidate the roles of the NRKs in skeletal muscle NADþ
salvage, we focused on the muscle-speciﬁc importance of NRK2 and
have generated a model with constitutive ablation of the Nmrk2 gene
(NRK2KO). NRK2KOmice were born at anticipated Mendelian ratios and
displayed no gross abnormalities. No Nmrk2 mRNA or protein could be
detected in any NRK2KO tissue examined, which included a range of
skeletal and cardiac tissues (Figure 4AeB). 12e14 week old male and
female mice were equivalent to WT control mice in terms of total body
weight and lean mass for a range of muscle beds (Figure 4CeD). To
induce metabolic stress and examine a role for NRK2 in skeletal muscle
metabolic adaption, mice were subjected to an endurance exercise
protocol. Again, total body weight and lean mass for a range of muscle
beds were unchanged in NRK2KO mice (Figure 4EeF). Assessment ofopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 823
Figure 2: Patterns of NADD biosynthesis gene expression during skeletal muscle differentiation and muscle development. 8 day differentiation time course of Nmrk1 (A),
Nmrk2 (B), and Nampt (C) mRNA expression in C2C12 and primary myotubes (n ¼ 3e4). 8-day C2C12 myotube differentiation time course of NADþ biosynthesis enzyme protein
expression (D).
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Figure 3: Precursor availability and skeletal muscle NADD biosynthesis. (A) Primary myotube NADþ levels following 24 h 0.5 mM NADþ precursor supplementation (n ¼ 4)
determined using an NADþ cycling assay. (B) Primary myotube NADþ content following 24 h 0.5 mM NAD precursor supplementation with or without FK866 inhibition of NAMPT
(* ¼ signiﬁcant from DMSO control and # ¼ signiﬁcant from FK866 treated control) (n ¼ 4) determined using the NADþ cycling assay. (C) Basal and maximal mitochondrial
respiration following 24 h NR supplementation with or without FK866 inhibition (n ¼ 3). (D) Transcriptional regulation of NADþ biosynthesis genes, Nmrk1, Nmrk2, and Nampt
following 24 h NR supplementation with or without FK866 inhibition of NAMPT (n ¼ 3).
Table 1e Targeted LC-MS NADþmetabolome of primary myotubes treated
with NR (0.5 mM) and/or FK866 (100 nM).
Metabolites
(pmol/mg)
Control NR FK866 FK866 þ NR
NAD(H) 790.2  54.3 1968.1  518.1*y 253.8  25.7 1564.4  207.6y
NADP(H) 90.5  3.1 186.4  62.1 55.1  23.5 98.4  20.1
NR 4.9  0.6 73.6  9.5*y 9.9  2.0 112.1  11.2*y
NAM 834.2  29.8 1064.2  172.4y 354.1  43.3* 973.1  75.8y
ADPr 535.3  198.4 400.2  54.1 326.6  86 537.5  104.3
NMN ND 107.9  26.5*y 3.8  0.7 79.6  12.1*y
Na ND ND ND ND
NaR ND 1.7  0.2*y 0.1  0.1 1.9  0.2*y
NaAD ND 14.9  5.6*y ND 8.4  2
NaMN ND ND ND ND
*Signiﬁcant to control, ysigniﬁcant to FK866 treated, n ¼ 3.muscle ﬁber cross-sectional area showed no signiﬁcant differences in
proportions of ﬁbre size in NRK2KO quadriceps compared to WT
(Figure 4G). Similarly, muscle ﬁber type distribution assessed for
myosin heavy chains (MHC) MHC1, MHC2a, MH2b, and MHCX in slow
twitch rich soleus, and fast twitch rich TA muscle were normal and at
expected proportions (Figure 4HeI).
3.4. NRK2 deﬁciency minimally impacts the skeletal muscle NADþ
metabolome
Recent evidence has shown that NR can elevate muscle NADþ when
administered to mice or cultured cells [22]. To ascertain the effect of
NRK2 deﬁciency on muscle levels of NADþ and related metabolites we
used LC-MS-based targeted quantitative NADþ metabolomics [33].
This method allows quantiﬁcation of NADþ as well as associated
metabolites to determine the wider effect loss of NRK2 has on NADþ
metabolism. Surprisingly, NADþ levels in quadriceps tissue from
NRK2KO mice were shown not to be deﬁcient compared to WT control
tissue (Figure 5A). The NADþ precursors NR and NAM were un-
changed, but a signiﬁcant increase in NMN was detected (Figure 5C).
Furthermore, no differences in NADP, ATP, ADP, or the NADþMOLECULAR METABOLISM 6 (2017) 819e832  2017 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.comconsumption product ADPr were detected (Figure 5A). To conﬁrm the
NADþ data generated by LC-MS, NADþ levels were independently
measured using a colorimetric cycling assay and by HPLC [32], whichopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 825
Figure 4: Validation and characterization of NRK2KO mice. (A) mRNA expression of Nmrk2 in WT and NRK2KO quadriceps muscle, heart, and liver tissue. (B) Protein
expression of NRK2 across metabolic tissues from WT and NRK2KO mice. (C) Whole body weight of 12 week old WT and NRK2KO mice. (D) Tissue weight of skeletal and cardiac
muscle from 12 week old WT and NRK2KO mice. (E) Whole body weight of WT and NRK2KO mice following 6 weeks of endurance exercise training. (F) Tissue weight of skeletal
and cardiac muscle from WT and NRK2KO mice following 6 weeks of endurance exercise training. (G) Muscle ﬁber cross-sectional area as a proportion of all ﬁbers in WT and
NRK2KO quadriceps. Fiber-type composition of TA (H) and soleus (I) skeletal muscle from WT and NRK2KO mice following 6 weeks of endurance exercise training. (All data
n ¼ 3e6).
Original Articleconﬁrmed that there were no signiﬁcant alterations to tissue NADþ and
NADH levels (Sup. 1CeD).
Finally, we examined the expression of key NADþ salvage and
biosynthetic genes in response to loss of Nmrk2. We did not detect any
adaptive changes in Nmrk1 or Nampt but did detect increased
expression of Pnp (2-fold) and CD157 (4-fold) (Figure 5B). Purine826 MOLECULAR METABOLISM 6 (2017) 819e832  2017 The Authors. Published by ElsevNucleoside Phosphorylase (PNP) is involved in purine metabolism and
has activity to convert NR to NAM [45]. CD157 has NADþ nucleotidase
activity liberating cADP-ribose and NAM [46]. These adaptive re-
sponses in gene expression, to compensate for loss of NRK2 in living
mice, may have more long-term consequences for NADþ salvage and
require further assessment.ier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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3.5. NRKs are essential for exogenous NR and NMN utilization to
NADþ in cultured muscle cells
To better understand the interactions and contributions of muscle NRK
1, NRK2, and NAMPT to NR and NMN precursor salvage we employed
a primary muscle culture system to derive myotubes with combina-
torial single, double, and triple NRK1/2 and NAMPT loss of function.
These experiments were conducted using NRK1 and 2KO mice as
reported by Ratajczak et al. [28]. Firstly, due to the highly muscle-
speciﬁc nature of NRK2, we assessed expression of key muscle dif-
ferentiation markers and NADþ signaling genes over myotube differ-
entiation in all the NRKKO models and found that expression was not
altered, conﬁrming that the NRKs are not essential for myotube dif-
ferentiation (Sup. 2A,B).
Basal NADþ levels in NRK single or double KO (DKO) cells were
comparable to those of WT cells (Sup. 2C). Similarly, but to a lesser
extent than in the WT myotubes, single NRK1KO and NRK2KO myo-
tubes were still able to enhance NADþ levels following NR supple-
mentation, more so in NRK2KO cells compared to NRK1KO cells
(43.25% increase in NADþ versus 23.5%), suggesting functional
redundancy of the NRKs to generate NADþ from available NR.Figure 5: NADD availability and signaling in NRK2KO mice. (A) LCMS-based targeted
skeletal muscle tissue (n ¼ 6). (B) Fold change in mRNA expression of NADþ related sig
MOLECULAR METABOLISM 6 (2017) 819e832  2017 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.comHowever, NR was unable to increase NADþ in double KO cells with less
than a 1% change from untreated (Figure 6AeC, left).
In hepatocytes, extracellular NMN is converted to NR extracellularly
such that both NR and NMN require NRK1 activity to convert these
compounds to intracellular NMN and NADþ [28]. In unstressed
NADþ replete cells NMN supplementation could not augment NADþ
levels in NRK1KO, and to a lesser degree NRK2KO, such that
double KO cells are effectively unresponsive to NMN (Figure 6AeC,
left).
We then examined the ability of NR and NMN to rescue cells depleted
of NADþ following 24 h NAMPT inhibition (Figure 6AeC, right). NAMPT
inhibition substantially depleted cellular NADþ content in WT and all
the NRK loss of function cell cultures (Figure 6AeC, right). NR and
NMN were able to recover, but not boost, NADþ levels following FK866
inhibition in NRK2KO and, to a lesser extent, NRK1KO myotubes.
However, neither NR nor NMN supplementation was able to recover
NADþ depletion in DKO myotubes, again clearly indicating the NRK
dependency of NMN conversion to NADþ (Figure 6AeC, right). In all
instances, 10-fold excess NAM (5 mM) is required to overcome NAMPT
inhibition (Sup. 2D).NADþ metabolomics to quantify NADþ and related metabolite levels in WT and NRK2KO
naling genes in NRK2KO skeletal muscle compared to WT (at Y axis ¼ 1) (n ¼ 4).
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Figure 6: Manipulations to skeletal muscle NADD biosynthesis pathways. (A) NRK1KO, (B) NRK2KO, and (C) NRK double KO (DKO) primary myotubes supplemented with
0.5 mM NADþ precursors for 24 h (left) and corresponding primary myotubes supplemented with 0.5 mM NADþ precursors for 24 h following 1 mM FK866 mediated NAMPT
inhibition (right). For clarity, all data is presented as percent change in NADþ compared to DMSO only control (100%) (all groups n ¼ 4 and signiﬁcance determined between WT
and corresponding KO from actual NADþ content by two-way ANOVA using Bonferroni’s post-test).
Original ArticleThese data show that while NAMPT is the primary pathway for
maintaining NADþ turnover in skeletal muscle, the NRKs are essential
for utilizing exogenous NR and NMN to enhance cellular NADþ.
4. DISCUSSION
Mounting evidence supports the notion that enhancing tissue NADþ
availability has beneﬁcial effects on metabolic health in the context of828 MOLECULAR METABOLISM 6 (2017) 819e832  2017 The Authors. Published by Elsevmetabolic disease and physiological decline [22,23,47e49]. The
leading method to accomplish NADþ augmentation is through dietary
supplementation with NR and NMN. Although they have a similar ca-
pacity to raise NADþ and promote metabolic beneﬁt, the tissue-
speciﬁc routes of their metabolism remain obscure. Skeletal muscle
exhibits a decline in NADþ in a number of physiological, metabolic, and
genetic scenarios, all associated with defects in muscle physiology and
mitochondrial function [7,50,51]. Here we have explored NADþier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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salvage and biosynthesis in skeletal muscle and identiﬁed NRKs as
critical to the availability of both NR and NMN to NADþ in skeletal
muscle cells.
NADþ biosynthesis in skeletal muscle appears restricted to two main
salvage pathways involving the rate-limiting enzymes NAMPT, NRKs,
and NMNAT. While basal NAMPT and, to a degree, NRK1 display
ubiquitous expression, NRK2 displays a muscle restricted pattern at
mRNA and protein level. De novo NADþ biosynthesis and the Preiss-
Handler NA salvage pathway play a minimal role in skeletal muscle
with limited or undetectable levels of expression of rate limiting
enzymes and metabolites. This supports previous metabolic enzyme
activity proﬁling data that found enzyme activity of NAD synthase e
the ﬁnal rate limiting enzyme for both de novo biosynthesis and NA
salvage e to be undetectable in skeletal muscle [34]. We endorse
this by showing that unlike NR, the acid version NaR, which is
metabolized by the NRKs and NMNATs e but also requires NAD
synthase activity for ﬁnal conversion to NADþ [40,41] e does not
appear able to act as an exogenous NADþ precursor in skeletal
muscle.
Depletion of NAMPT activity in muscle leads to a severe reduction
(85%) in muscle NADþ availability; yet, at least for young mice, no
gross NADþ relatable phenotype was observed [38]. However, with
advancing age (7 months), this chronic reduction in NADþ manifests
with impaired mitochondrial function, loss of muscle ﬁber integrity,
strength, and performance [38]. Although NAMPT is critical to basal
NADþ biosynthesis, exogenous NAM appears to be a poor precursor
for NADþ boosting in muscle compared to NR and NMN due to poor
conversion to NADþ and its inhibitory activity towards sirtuins [52]. We
found that NR supplementation could signiﬁcantly boost NADþ in the
context of reduced NADþ levels following NAMPT inhibition and rescue
concurrent defects in mitochondrial energy metabolism. Despite NR
rescuing NADþ depletion and some of the effects of metabolic chal-
lenge in vivo [22], our data suggest that increasing NADþ availability in
skeletal muscle by NR supplementation does not enhance oxidative
metabolism of ‘healthy’ NADþ replete muscle cells. Muscle-speciﬁc
NAMPT overexpressing mice showed that a 50% increase in NADþ
could not stimulate mitochondrial biogenesis or enhance mitochondrial
metabolism in young skeletal muscle [53]. Our results show that when
NADþ is enhanced through NR supplementation, NAM and ADPr levels
are unchanged, whereas there is a decrease following NADþ depletion
(Table 1). As NAM and ADPr are metabolites of NADþ signaling
(products of SIRT based NADþ consumption) [54], this indicates that
although a reduction of NADþ can limit NADþ signaling and ultimately
hinder mitochondrial metabolism, basal NADþ content alone is not
limiting to NADþ signaling, at least in healthy skeletal muscle.
Though NRK2 appears to be restricted to muscle, loss-of-function had
no effect on basic parameters of muscle physiology, perhaps reﬂecting
the unstressed nature of young muscle in this study, and in line with
the work of Frederick et al. [38]. Again, this also suggests that NAMPT
is more than sufﬁcient to match NADþ recycling to its metabolic
clearance. Measuring the quadriceps tissue NADþ related metabolome
was unremarkable other than for a 50% increase in NMN. Similarly,
NAMPT and NRK1 were unaffected at the level of gene expression and
may suggest that no overt stress response was initiated. However, we
did note elevation in the expression of Pnp and CD157. PNP can
convert NR to NAM and CD157 converts extracellular NADþ to ADPr
and NAM [45,46]. While this does not manifest as raised NAM level in
muscle, it may reﬂect raised NMN that serves to balance NADþ
availability suggesting a minor adaptation to the loss of NRK2.
We originally postulated that NRK2 would be more important than
NRK1 in skeletal muscle for NR salvage due to its predominantMOLECULAR METABOLISM 6 (2017) 819e832  2017 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.comexpression. However, our in vivo data and work by Ratajczak et al.
showing that NRK1 controls NR and NMN metabolism in mammalian
cells [28] led us to examine more closely the dependency of NR and
NMN on each NRK. Using combinatorial muscle cultures of single and
double NRK1/2 KO cells we conﬁrmed that NR is exclusively metab-
olized by the NRK enzymes in skeletal muscle with no change to
cellular NADþ levels in DKO primary myotubes following NR supple-
mentation, which was strikingly evident in NADþ depleted cells. Both
NRK1 and NRK2 single KO cells demonstrate a level of redundancy in
their ability to respond to NR, though clearly being submaximal
compared to control cells.
NMN is metabolized to NADþ downstream of NRKs and NAMPT, yet
exogenous NMN supplementation was unable to be metabolized to
NADþ in DKO cells, again most strikingly in the context of severe NADþ
depletion. While there is a level of redundancy in the single KO cells,
the data implicate NRK1 as being more critical for regulating NMN
entry into the cell. Recent ﬁndings by Ratajczak et al. have shown that
NRK1 regulates exogenous NMN salvage in liver tissue and cells. They
identiﬁed a requirement for NMN to be metabolized extracellularly to
NR before hepatic uptake, then re-phosphorylated by NRK1 back to
NMN [28]. Similar data also have highlighted that human cells can
metabolize NMN to NR intracellularly utilizing cytosolic 50-nucleotid-
ases [40]. The data presented here in primary WT and loss-of-function
myotubes corroborate these ﬁndings and reveal the NRKs critical role
for both NR and NMN conversion to NADþ.
Positive health effects of enhancing NADþ availability have been
demonstrated in muscle [55]. Acipimox (NA analogue) treatment
improved aspects of mitochondrial physiology in type 2 diabetic
muscle. However, the effects on NADþ availability were small and the
mechanisms unclear, and the therapeutic potential of acipimox limited
due to a range of adverse effects including insulin resistance and
GPR109A receptor activation leading to ﬂushing and therefore poor
compliance [15]. The inhibition of PARPs, sparing and elevating NADþ,
leading to enhanced mitochondrial function and biogenesis through
activation of SIRT1-PGC-1a axis has been demonstrated as being
effective in muscle [56e58].
However, supplementation with NR and NMN to boost cellular NADþ
pools in a range of scenarios appears to be the most promising
strategy [19,20,22,48,51,59e63]. NR and NMN based NADþ repletion
in skeletal muscle can revitalize stem cells and augment physiological
and mitochondrial function in aged mice [49]. Furthermore, NADþ can
also act to regulate proteineprotein interactions that inﬂuence DNA
repair through control of PARP activity, and NMN or NR repletion of
NADþ in ageing could support efﬁcient DNA repair capacity while
maintaining the positive effects of sirtuin activation [64].
While NR is naturally available in the human diet, with appreciable
levels measured in milk, the main source of NR, NMN, NAM, and NA is
the NAD(P) (H) pool available through the digestion of whole, unpro-
cessed food [27]. Oral NR administration to humans has recently
demonstrated effectiveness in boosting circulating and white blood cell
NADþ levels, with further work required to determine the importance
for muscle NADþ repletion [26].
These data establish that muscle has a level of redundancy in its ability
to metabolize NR and therefore NMN. Despite NRK2 being restricted to
muscle and being highly expressed, basal NADþ turnover does not
seemingly require NRK activity. However, NRK1 and to a smaller de-
gree NRK2 are gate-keepers of NR and NMN salvage. Importantly,
NADþ depletion and energetic stress can lead to augmented NRK2
expression in a range of tissues such as neurons, cardiac, and skeletal
muscle [65e67]. Thus, beyond basal NADþ turnover, regulated NRK2
activity may serve an additional role in cellular metabolism involvingopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 829
Original ArticleNR phosphorylation, potentially more critical to stress adaptation when
there is need to enhance NR/NMN metabolism to defend metabolic
integrity.
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